#8 Global Dialogue on Health Security

ルスセキュリティダイアログ Global Dialogue on Health Security

Facing COVID-19 crisis, we are here to ensure healthy lives and promote well-being for all at all ages. It is important in particular to address healthcare resources and policies to prepare against health emergency crisis, through building resilient global community and knowledge-based resource hubs for health crisis management. GHIPP is strengthening global partnership by sharing knowledge and lessons learned and creating new regional community for health resilience. For this purpose, GHIPP will conduct a series of online speakers’ sessions.

#8 Dialogue: May 14, 2021 09:00-10:00 JST (May 13, 2021 20:00-21:00 EDT)
Topic: “COVID-19 and Beyond: Harnessing Human Immunity as the Next Frontier of Science"
Policy Program at GRIPS invites you to the 8th dialogue series on health security.We are excited to welcome Mr. Ted Schenkelberg, Co-founder and COO of the Human Vaccines Project (HVP).The HVP is leveraging cutting-edge technologies to decode the human immune system, and to unlock new preventions, diagnostics, and treatments for some of the world's most devastating diseases.
Speaker: Mr. Ted Schenkelberg, M.B.A., M.P.H. COO and co-founder of the Human Vaccines Project
Commentator: Dr. Kiyoshi Kurokawa (GHIPP)
Facilitator: Dr. Hiromi Murakami (GHIPP)
Tool: Zoom

Language: English
Fee: Free
Deadline: May 13, 2021
More details http://www3.grips.ac.jp/~GHIPP/en/dialogue/hsd8/

Speakers' bio:
Ted Schenkelberg, M.B.A., M.P.H., is Co-Founder and Chief Operating Officer of the Human Vaccines Project. And brings more than 20 years of experience in biomedicine and global health.

Previously, Schenkelberg worked as a strategic consultant in the global health and biotech space, including work for a leading Indian health system and national initiatives on reproductive health and antibiotic resistance. He served for more than seven years as a Director at the International AIDS Vaccine Initiative (IAVI) where he played a key role in building a $50 million global vaccine design program.

Schenkelberg brings strong private sector experience having worked as a licensed health and technology analyst at Carnegie Capital, an investment firm with more than $1 billion under management and administration. He also has served on the board of directors for the African Services Committee in New York City, the largest U.S. organization supporting African immigrants and asylum seekers.

Schenkelberg has an M.P.H. in infectious disease from The Johns Hopkins Bloomberg School of Public Health, an M.B.A. from The University of Chicago Booth School of Business where he completed joint graduate work at the London School of Economics, a B.A. (honors) from Grinnell College, and is a Visiting Scientists at the Harvard T.H. Chan School of Public Health and HVP, the Human Immunomics Initiative.

Kiyoshi Kuorkawa: Professor, Emeritus, National Graduate Institute for Policy Studies and the University or Tokyo
Hiromi Murakami: Visiting Scholar, National Graduate Institute for Policy Studies

If you have any questions, please contact GRIPS GHIPP Hiromi Murakami at hi-murakam (at) grips.ac.jp
Thank you for your interest, and we look forward to having you at our newly launched Glogal Dialogue on Health Security. ご質問や不明な点などありましたら、Global Health Innovation Policy Program 村上までご連絡くださいませ。
We use your information for this event series only.
  • イベント詳細情報を更新しました。 Diff#1006850 2021-05-13 07:32:40
More updates
Fri May 14, 2021
9:00 AM - 10:00 AM JST
Add to Calendar
Online event
Zoom ticket (Free) FULL
Global Health Innovation Policy Program

[PR] Recommended information